7 February 2023

Last updated: Monday 6 February 2023

Research Directory

Checkpoint inhibitors are focus at ESMO

Biotech companies advised to conserve cash

Viable malaria vaccine moves a step closer

Microbiome-based therapies as anti-cancer agents

Direct cell reprogramming: Mogrify and Astellas to address hearing loss

Antibody-drug conjugates come to the fore

The microbiome and cancer

The lasting value of small molecule drugs

Investigating a functional cure for hepatitis B

Oral microbiota provides new clue to brain disorders